136941-53-2

Upstream product

• 143093-33-8 isopropyl β-aminocrotonate 
• 141294-04-4 2-[1-(2-Nitro-phenyl)-meth-(Z)-ylidene]-3-oxo-butyric acid 1,1,3-trioxo-1,3-dihydro-1λ⁶-benzo[d]isothiazol-2-ylmethyl ester 
• 113658-93-8 (1,1,3-trioxo-2,3-dihydro-1,2-benzisothiazol-2-yl)methyl acetylacetate 
• 552-89-6 2-nitro-benzaldehyde 

Relevant academic research and scientific papers

1,4-dihydropyridine derivatives, a process for their preparation and their use for influencing the blood flow

The invention relates to new 1,4-dihydropyridine derivatives of the general formula I STR1 in which R1, R2, R3 and n have the meaning stated in the patent claims. The compounds of the invention have a vasodilatory effect and are therefore suitable for the treatment of hypertension. Some of the compounds have a vasoconstrictory effect and can therefore be used for the treatment of hypotension.

Synthesis of 3-1,4-Dihydropyridine-3,5-dicarboxylate Derivaties as Calcium Channel Modulators

1,4-Dihydropyridine (DHP) derivatives with a 1,2-benzisothiazol-3-one 1,1-dioxide group, linked through an alkylene bridge to the C-3 carboxylate of the DHP ring, with both vasoconstricting and vasorelaxant properties were obtained.In blocking Ca2+/

New 1,4-dihydropyridine derivatives, a process for their preparation and their use for influencing the blood flow

The invention relates to new 1,4-dihydropyridine derivatives of the general formula I in which R1, R2, R3 and n have the meaning stated in the patent claims. The compounds of the invention have a vasodilatory effect and are therefore suitable for the treatment of hypertension. Some of the compounds have a vasoconstrictory effect and can therefore be used for the treatment of hypotension.